Keeping a Low Profile: Insulinoma

      A young patient experienced a major lapse of memory, which led to hospitalization and the diagnosis of a rare but curable disease. An otherwise healthy 21-year-old man was brought to the emergency department by his partner after he forgot to pick her up from the airport despite several reminders. His partner and father described that he had become forgetful over the past 6 months, unreliable in his responsibilities, and increasingly impatient with a quick temper. He experienced bouts of confusion lasting minutes during which he was unable to answer questions and noticed diffuse body sweating and shaking of his arms. He began to forget recent conversations and events. He did not seek medical attention despite being advised to do so by family. He denied fevers, chills, focal pain, headaches, neck stiffness, weight changes, weakness, speech or vision changes, or mood symptoms.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Whipple A.O.
        The surgical therapy of hyperinsulinism.
        J Int Chir. 1938; 3: 237
        • van Bon A.C.
        • Benhadi N.
        • Endert E.
        • Fliers E.
        • Wiersinga W.M.
        Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
        Neth J Med. 2009; 67: 274-278
        • Kumar D.
        • Mehtalia S.D.
        • Miller L.V.
        Diagnostic use of glucagon-induced insulin response: studies in patients with insulinoma or other hypoglycemic conditions.
        Ann Intern Med. 1974; 80: 697-701
        • Lupsa B.C.
        • Chong A.Y.
        • Cochran E.K.
        • Soos M.A.
        • Semple R.K.
        • Gorden P.
        Autoimmune forms of hypoglycemia.
        Medicine (Baltimore). 2009; 88: 141
        • Noone T.C.
        • Hosey J.
        • Firat Z.
        • Semelka R.C.
        Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
        Best Pract Res Clin Endocrinol Metab. 2015; 19: 195-211
        • Cryer P.E.
        • Axelrod L.
        • Grossman A.B.
        • et al.
        Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.
        J Clin Endocrinol Metab. 2009; 94: 709-728
        • Service F.J.
        • McMahon M.M.
        • O'Brien P.C.
        • Ballard D.J.
        Functioninginsulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
        Mayo Clin Proc. 1991; 66: 711
        • Placzkowski K.A.
        • Vella A.
        • Thompson G.B.
        • et al.
        Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007.
        J Clin Endocrinol Metab. 2009; 94: 1069
        • Thakker R.V.
        • Newey P.J.
        • Walls G.V.
        • et al.
        Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
        J Clin Endocrinol Metab. 2012; 97: 2990
        • Okabayashi T.
        • Shima Y.
        • Sumiyoshi T.
        • et al.
        Diagnosis and management of insulinoma.
        World J Gastroenterol. 2013; 19: 829-837
        • Service F.J.
        Recurrent hyperinsulinemic hypoglycemia caused by an insulin-secreting insulinoma.
        Nat Clin Pract Endocrinol Metab. 2006; 2: 467
        • Hirshberg B.
        • Cochran C.
        • Skarulis M.C.
        • et al.
        Malignant insulinoma: spectrum of unusual clinical features.
        Cancer. 2005; 104: 264